Medicure (MCUJF) Shares Outstanding (Weighted Average) (2009 - 2026)
Medicure (MCUJF) recorded quarterly Shares Outstanding (Weighted Average) of $29.17 in Q1 2026, down 100.0% quarter-over-quarter from $58.1 million in Q4 2025, and down 40.21% on a YoY basis from $48.78 in Q1 2025.
Medicure (MCUJF) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Medicure's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $29.17 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 40.21% year-over-year to $29.17; the TTM figure through Mar 2026 stood at $29.17 (down 40.21% YoY), while the FY2025 annual figure was $58.1 million, changed 0.17% from the prior year.
- Shares Outstanding (Weighted Average) was $29.17 for Q1 2026 at Medicure, down from $58.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $58.9 million in Q3 2025 to a low of $7.33 in Q3 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $14.2 million across 5 years, with a median of $48.78 in 2025.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) slumped 100.0% in 2022, then soared 803046544.55% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $95.77 in 2022, then soared by 8004214.54% to $7.7 million in 2023, then surged by 656.52% to $58.0 million in 2024, then rose by 0.17% to $58.1 million in 2025, then plunged by 100.0% to $29.17 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $29.17 (Q1 2026), $58.1 million (Q4 2025), and $58.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Medicure | - | - | 2.57 Mn | 29.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.17 |
| Dec 31, 2025 | 58.09 Mn |
| Sep 30, 2025 | 58.87 Mn |
| Jun 30, 2025 | 58.47 Mn |
| Mar 31, 2025 | 48.78 |
| Dec 31, 2024 | 57.99 Mn |
| Sep 30, 2024 | 7.33 |
| Jun 30, 2024 | 21.93 |
| Mar 31, 2024 | 22.26 |
| Dec 31, 2023 | 7.67 Mn |
| Sep 30, 2023 | 44.76 |
| Jun 30, 2023 | 37.22 |
| Mar 31, 2023 | 22.19 |
| Dec 31, 2022 | 95.77 |
| Sep 30, 2022 | 84.34 |
| Jun 30, 2022 | 47,060.44 |
| Mar 31, 2022 | 39.47 |
| Dec 31, 2021 | 8.13 Mn |
| Sep 30, 2021 | 206.55 |
| Jun 30, 2021 | 130.16 |